Search
Search Constraints
You searched for: ISSN 1359-6446Limit your search
- Journal Article2,135
- Drug discovery today2,135
- Kinch, Michael S. 30
- Kesharwani, Prashant 26
- Sahebkar, Amirhossein 18
- Iyer, Arun K. 15
- Chen, Zhe-Sheng 13
- Ekins, Sean 12
- Lu, Yi 10
- Sau, Samaresh 10
- Wu, Wei 10
- Almalki, Waleed H. 9
- 615.1 2,135
- Drugs -- Design -- Periodicals 2,135
- Drugs -- Research -- Periodicals 2,135
- New molecular entities -- FDA -- Drug discovery 2
- 3D Three-dimensional -- ALN-HA-C18 Alendronate-hyaluronan-octadecanoic acid -- APNP Amphiphilic nanoparticle -- Bad B-cell leukemia/lymphoma-2 (Bcl-2)-associated agonist of cell death -- CA Carbonated apatite -- CD Cyclodextrin -- Cur Curcumin -- Cyt C Cytochrome C -- C6 C6 ceramide -- DOX Doxorubicin -- ECM Extracellular matrix -- EMT Epithelial-mesenchymal transition -- ERK Extracellular signal-regulated protein kinase -- HA hyaluronan, hyaluronic acid -- Ha Hydroxyapatite -- HHC Hexahydrocurcumin -- HO-1 Haem oxygenase-1 -- IAP Inhibitor of apoptosis -- IC25 Quarter maximal inhibitory concentration -- IC50 Half maximal inhibitory concentration -- IMA Invertible micellar polymer nanoassembly -- JAK Janus kinase -- JNK c-Jun N-terminal kinase -- LPN Lipid-coated polymeric nanoparticle -- MAPK Mitogen-activated protein kinase -- MMP-2 Matrix metalloproteinase-2 -- NF-κB Nuclear factor κ-light-chain enhancer of activated B cell -- NMP Nuclear matrix protein -- NP Nanoparticle -- PARP Poly(adenosine diphosphate-ribosyl)polymerase -- pCD Cyclodexin-based polymer -- pDA Polydopamine -- PI3K Phosphoinositide 3-kinase -- P-gp P-glycoprotein -- PN Polymeric nanoparticles -- RECK Reversion-inducing cysteine-rich protein with Kazal motifs -- ROS Reactive oxygen species -- SF Silk fibroin -- SLCP Solid lipid curcumin particle -- STAT3 Signal transducer and activator of transcription 3 -- Tcf T-cell factor -- Ti Titanium -- TiO2 Titanium dioxide -- uPA Urokinase plasminogen activator -- Vit Vitamin 1
- 3D cell culture -- glioma -- tumor microenvironment -- 3D bioprinter -- scaffolds -- hydrogels 1
- 3D in vitro models -- Oncology drug development -- Technology landscape 1
- 4D printing -- Shape memory polymer -- Biomedical application -- Drug delivery -- 5D printing 1
- 5-FU 5-Fluorouracil -- AKT Protein kinase B -- AMPK AMP-activated protein kinase -- ATG6 Autophagy-related gene 6 -- BRD4 Bromodomain-containing protein 4 -- CJ Chaetocochin J -- CK2 Casein kinase 2 -- CRC Colorectal cancer -- ERK/MAPK Ras/Raf/MEK/ERK mitogen-activated protein kinase -- HDAC Histone deacetylases -- IC50 The half maximal inhibitory concentrations -- LIF Leukemia inhibitory factor -- MAPK Mitogen-activated protein kinase -- mTOR Mammalian target of rapamycin -- mTORC1 mTOR complex 1 -- OA Oleanolic acid -- PAM PI3K/AKT/mTOR -- PIK3C3 phosphoinositide 3-kinase class III -- PI3K Phosphatidylinositol-3-kinase -- SGK1 Serum/glucocorticoid-regulated kinase 1 -- STAT3 Signal transducer and activator of transcription 3 -- ULK1 Unc-51-like autophagy activating kinase 1 -- VPS34 Vacuolar protein sorting 34 1
- AA Accelerated Approval (US) or Accelerated Assessment (EU) -- BTD breakthrough therapy designation -- BTK Bruton's tyrosine kinase -- CMA conditional marketing authorization -- CR complete response -- EMA European Medicines Agency -- FDA US Food and Drug Administration -- FT Fast Track -- IND investigational new drug -- NDA new drug application -- NME new molecular entity -- NMPA China National Medical Products Administration -- ORR overall response rate -- OS overall survival -- PD-1 Programmed cell death Protein 1 -- PD-L1 Programmed cell death Ligand 1 -- PFS progression free survival -- PMDA Pharmaceuticals and Medical Devices Agency -- PR Priority Review -- PRIME Priority Medicines -- RTOR Real-Time Oncology Review -- SFDA Saudi Food and Drug Administration -- SRA stringent regulatory authority -- WHO World Health Organization 1